G

Genova Inc
TSE:9341

Watchlist Manager
Genova Inc
TSE:9341
Watchlist
Price: 610 JPY 1.5% Market Closed
Market Cap: 10.9B JPY

Wall Street
Price Targets

Price Targets Summary
Genova Inc

There are no price targets for Genova Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Genova Inc Competitors:
Price Targets
4483
JMDC Inc
42% Upside
OMDA
Omda AS
26% Upside
3902
Medical Data Vision Co Ltd
74% Downside
SLP
Simulations Plus Inc
20% Upside
FORA
Forian Inc
3% Upside
COP
CompuGroup Medical SE & Co KgaA
28% Downside
DOCS
Doximity Inc
59% Upside
300451
B-SOFT Co Ltd
13% Upside

Revenue
Forecast

Revenue Estimate
Genova Inc

For the last 3 years the compound annual growth rate for Genova Inc's revenue is 28%. The projected CAGR for the next 2 years is 25%.

28%
Past Growth
25%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Genova Inc

Operating Income forecast
is not available for
Genova Inc

Net Income
Forecast

Net Income Estimate
Genova Inc

For the last 3 years the compound annual growth rate for Genova Inc's net income is 27%. The projected CAGR for the next 2 years is 42%.

27%
Past Growth
42%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Genova Inc's stock price target?
Not Available

Genova Inc doesn't have any price targets made by Wall Street professionals.

What is Genova Inc's Revenue forecast?
Projected CAGR
25%

For the last 3 years the compound annual growth rate for Genova Inc's revenue is 28%. The projected CAGR for the next 2 years is 25%.

What is Genova Inc's Net Income forecast?
Projected CAGR
42%

For the last 3 years the compound annual growth rate for Genova Inc's net income is 27%. The projected CAGR for the next 2 years is 42%.

Back to Top